These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6601552

  • 1. Complement activation by antibodies to Sm in systemic lupus erythematosus.
    Sabharwal UK, Fong S, Hoch S, Cook RD, Vaughan JH, Curd JG.
    Clin Exp Immunol; 1983 Feb; 51(2):317-24. PubMed ID: 6601552
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.
    Pollard KM, Tan EM.
    Clin Exp Immunol; 1985 Jun; 60(3):586-96. PubMed ID: 4017287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody class differences are detected in anti-nRNP and anti-Sm antibodies directed against distinct antigen subunits.
    Williams DG, Stocks MR, Charles PJ, Maini RN.
    Rheumatol Int; 1986 Jun; 6(4):189-92. PubMed ID: 3491411
    [Abstract] [Full Text] [Related]

  • 7. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
    López-Longo FJ, Monteagudo I, González CM, Moreno AC, Rodríguez Mahou M, Grau R, Carreño L.
    J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
    [Abstract] [Full Text] [Related]

  • 8. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens.
    Field M, Williams DG, Charles P, Maini RN.
    Ann Rheum Dis; 1988 Oct; 47(10):820-5. PubMed ID: 3143318
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complement-activating abilities of defined antinuclear antibodies.
    Kanayama Y, Peebles C, Tan EM, Curd JG.
    Arthritis Rheum; 1986 Jun; 29(6):748-54. PubMed ID: 3487323
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-nRNP and anti-Sm antibodies.
    Sharp GC.
    Arthritis Rheum; 1982 Jul; 25(7):757-60. PubMed ID: 6980651
    [No Abstract] [Full Text] [Related]

  • 18. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP, Suzuki H, Nakamura RM.
    Diagn Immunol; 1985 Jul; 3(1):24-8. PubMed ID: 3922661
    [Abstract] [Full Text] [Related]

  • 19. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
    Milgrom H, Curd JG, Kaplan RA, Müller-Eberhard HJ, Vaughan JH.
    J Immunol; 1980 Jun; 124(6):2780-5. PubMed ID: 7373050
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.